What it is.
Retaklik 2.0 combines retatrutide, a GLP-1, GIP and glucagon triple agonist, with cagrilintide, a long-acting amylin analogue. It brings two different metabolic hormone pathways into one pen.
Peptide · Pre-filled pen
Retaklik 2.0 35 mg pen.
Retaklik 2.0 combines retatrutide, a GLP-1, GIP and glucagon triple agonist, with cagrilintide, a long-acting amylin analogue.
- Strength
- 35 mg
- Volume
- 3 mL
- Purity
- 99% HPLC
- Research area
- Metabolic
Verified
Genuine Genovare product
This code matches one issued by Genovare. Keep your box until your work with it is finished.
Not recognised
We don't recognise this code
Check each digit and try again. Still not matching? Email us with a photo of the box and we'll look into it.
Couldn't check
We couldn't check your code just now
Something stopped the check from running. Refresh the page and try again. Your code has not been used up.
For laboratory research use only. Not for human consumption.
Product card
The pen, at a glance.
Strength, volume and pack details on one card, the same card that comes with every Retaklik 2.0 35 mg Pen.
- Strength per pen
- 35 mg / 3 mL
- Concentration
- 11.67 mg / mL
- Format
- Pre-filled pen
Reference profile
Reference profile
How it is used.
The pairing is studied in obesity and metabolic research, where the amylin and incretin pathways are compared and combined. Research tracks body weight, food intake and glucose control.
Quality
Tested before it's boxed.
Every batch is made in-house in Switzerland and tested for identity, purity and sterility before it is packed.
How we test
Every batch is tested for
- Identity LC-MS
- Content HPLC-UV
- Purity HPLC-UV
- Sterility USP <71>
- Endotoxins USP <85>
- Particulates USP <788>
